Local vax trials

THE first six participants in the clinical trial of two Melbourne-made Covid-19 vaccines have been safely administered their doses, a significant moment in the development of the new vaccine candidates.

The two vaccine candidates were created by researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and Monash Institute of Pharmaceutical Sciences (MIPS) and are distinct from existing vaccines in use around the globe.